Topic Hub
16 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 16 of 16 clinical reviews.
Is metformin effective for cancer prevention? We review the clinical evidence, dosing protocols, and limitations of off-label metformin use for reducing cancer risk.
Read clinical reviewMetformin is FDA-approved for type 2 diabetes, but observational data suggest it may reduce cancer incidence. Here is what the trials show, what remains unproven, and how to monitor patients using metformin off-label for cancer risk reduction.
Read clinical reviewA physician-reviewed analysis of metformin's off-label use for cancer prevention, including trial data, proposed mechanisms, risk-benefit tradeoffs, and who might benefit most.
Read clinical reviewA clinical evidence summary of metformin's off-label use for cancer prevention, including key trials, biological mechanisms, and current guideline positions.
Read clinical reviewIs metformin a longevity drug? We review the biology, clinical trial data from TAME and beyond, GRADE evidence levels, off-label status, and what prescribers and patients need to know before considering metformin for aging.
Read clinical reviewEvidence-based monitoring guide for off-label metformin use in longevity. Covers B12 testing, renal function, lactic acidosis risk, and the clinical trials shaping anti-aging metformin protocols.
Read clinical reviewMetformin is prescribed off-label for longevity based on observational data and preclinical evidence. Here is what the clinical trials show, how physicians dose it, and what TAME will tell us.
Read clinical reviewA clinical review of metformin's off-label use for longevity, including trial data, AMPK mechanisms, side effects, and who may or may not benefit from anti-aging metformin therapy.
Read clinical reviewA clinical deep-dive into whether metformin works for non-alcoholic fatty liver disease (NAFLD): current evidence grade, off-label dosing protocols, and what the guidelines actually say.
Read clinical reviewMetformin is sometimes prescribed off-label for nonalcoholic fatty liver disease (NAFLD). This evidence summary reviews the clinical trial data, guideline positions, and practical considerations for metformin use in NAFLD.
Read clinical reviewMetformin is widely prescribed off-label for NAFLD, but clinical trials show limited histological benefit. Learn the real evidence, risks, tradeoffs, and better-studied alternatives.
Read clinical reviewMetformin is sometimes used off-label for nonalcoholic fatty liver disease (NAFLD). Learn what the evidence shows, how monitoring works, and what guidelines recommend.
Read clinical reviewMetformin is widely prescribed off-label for polycystic ovary syndrome (PCOS). Learn the dosing protocol, clinical evidence from key trials, side effects, and how it compares to other PCOS treatments.
Read clinical reviewMetformin is widely prescribed off-label for polycystic ovary syndrome (PCOS). Review the clinical trial evidence, guideline recommendations, dosing protocols, and expected outcomes for metformin in PCOS management.
Read clinical reviewMetformin is widely prescribed off-label for polycystic ovary syndrome (PCOS). Learn the clinical evidence, recommended doses, monitoring protocols, and what to expect from treatment.
Read clinical reviewA clinical evidence summary of off-label metformin use for weight maintenance, including trial data from the DPP/DPPOS, dosing guidance, and how it compares to newer GLP-1 therapies.
Read clinical review